InvestorsHub Logo
Followers 52
Posts 6521
Boards Moderated 3
Alias Born 01/02/2003

Re: None

Saturday, 12/24/2022 10:37:07 AM

Saturday, December 24, 2022 10:37:07 AM

Post# of 83055
Well, CVSI is in an interesting position heading into next year. I think 2023 and maybe into 2024 will be the time of buyouts and die outs. Read somewhere there are over 10,000 companies selling CBD products and that makes me wonder how are they staying in business. We don’t have all 10k operating at a loss, do we? As we head into the recession, I think we’ll see a reduction of the above number. I also think we will finally get into the price compression stage as companies try and maintain market share vs the competition. I don’t think we’ll get any help from the FDA anytime soon, so. Currently CVSI is at a market cap of 4.6 million, which is interesting since they claim an inventory of product valued at 7 million. Bad cash management? They do have a net income of neg- 15 million, not so good. They do have a few tools to use. Roughly 650 million more shares to dilute with and a up to a rev. split of 1 for 400 that is authorized but they haven’t pulled the trigger on yet. On the other hand, if they keep on losing sales what’s the point. Buy out or die out. Place your bets. IMO